SMK Act of 2025
Summary
The SMK Act of 2025, which increases operational costs and regulatory risk for social media platforms, has been forwarded by subcommittee. While $GOOGL and $SNAP show positive 7-day changes, $META and $PINS have experienced negative 30-day changes, indicating mixed market reaction to the sector.
Key Takeaways
- 1.The SMK Act of 2025 is actively progressing through Congress, having been forwarded by subcommittee.
- 2.The bill mandates product feature changes for social media platforms, increasing operational costs and regulatory risk.
- 3.The legislation is expected to reduce advertising revenue potential for social media companies by impacting a key demographic.
- 4.Market performance for social media companies is mixed, with $META and $PINS showing negative 30-day trends, while $GOOGL and $SNAP have positive 7-day changes.
Market Implications
The SMK Act of 2025 presents a bearish outlook for social media platforms due to increased compliance costs and potential revenue reduction. $META, currently trading at $569.1, has seen a substantial 11.75% decline over the last 30 days, indicating investor concern. $PINS, at $18.22, also shows a negative 8.95% change over the same period. While $GOOGL ($300.52) and $SNAP ($4.76) have experienced positive movements in the last 7 days, their long-term exposure to these regulatory changes remains. The bill's progression through the full committee will be a critical event for these companies, as it directly impacts their business model and profitability.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
No Fentanyl on Social Media Act
Parents Over Platforms Act
SCAM Act
Respect NATO Allies Act
Strong Start Act
Working Families Flexibility Act of 2025
Streamlining Federal Grants Act of 2026
To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.